This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
The strong association in this meta-analysis, presented at the 2024 ECTRIMS annual meeting, were drawn from 15 multicenter phase 3 treatment trials with 16,794 participants.
MDedge News